Secoisolariciresinol diglucoside regulates estrogen receptor expression to ameliorate OVX-induced osteoporosis.

Abstract

OBJECTIVE:

Secoisolariciresinol diglucoside (SDG) is a phytoestrogen that has been reported to improve postmenopausal osteoporosis (PMOP) caused by estrogen deficiency. In our work, we aimed to investigate the mechanism of SDG in regulating the expressions of ERs on PMOP model rats.

METHODS:

Ovariectomization (OVX) was used to establish PMOP model in rats. The experiment was allocated to Sham, OVX, SDG and raloxifene (RLX) groups. After 12-week treatment, micro-CT was used to detect the transverse section of bone. Hematoxylin and Eosin staining and Safranine O-Fast Green staining were supplied to detect the femur pathological morphology of rats. Estradiol (E2), interleukin-6 (IL-6), bone formation and bone catabolism indexes in serum were detected using ELISA. Alkaline phosphatase (ALP) staining was used to detect the osteogenic ability of chondrocytes. Immunohistochemistry and Western blot were applied to detect the protein expressions of estrogen receptors (ERs) in the femur of rats.

RESULTS:

Compared with the OVX group, micro-CT results showed SDG could lessen the injury of bone and improve femoral parameters, including bone mineral content (BMC) and bone mineral density (BMD). Pathological results showed SDG could reduce pathological injury of femur in OVX rats. Meanwhile, SDG decreased the level of IL-6 and regulated bone formation and bone catabolism indexes. Besides, SDG increased the level of E2 and conversed OVX-induced decreased the expression of ERα and ERβ.

CONCLUSION:

The treatment elicited by SDG in OVX rats was due to the reduction of injury and inflammation and improvement of bone formation index, via regulating the expression of E2 and ERs.

• Authors: Guofang Chen, Yansong Chen, Junyi Hong, Junwei Gao, Zhikun Xu
• Journal: Journal of orthopaedic surgery and research (J Orthop Surg Res) Vol. 18 Issue 1 Pg. 792 (Oct 24 2023) ISSN: 1749-799X [Electronic] England
• PMID: 37875947 (Publication Type: Journal Article)
• Copyright: © 2023. BioMed Central Ltd., part of Springer Nature.

Chemical References

• Receptors, Estrogen
• secoisolariciresinol diglucoside
• Interleukin-6
• Estrogens

Topics

• Female
• Humans
• Rats
• Animals
• Receptors, Estrogen
• Interleukin-6
• Osteoporosis (drug therapy, etiology, metabolism)
• Estrogens
• Bone Density
• Osteoporosis, Postmenopausal (drug therapy, etiology)
• Ovariectomy (adverse effects)